Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1975 May;11(5):1094–1099. doi: 10.1128/iai.11.5.1094-1099.1975

Superinfection in mice previously infected with Mycobacterium leprae.

L Levy
PMCID: PMC415184  PMID: 1091561

Abstract

Previous studies of the protection of mice by prior infection with Mycobacterium leprae in one hind footpad against challenge with M.leprae in the opposite hind footpad had produced conflicting results; therefore, the problem was restudied. In several experiments, BALB/c mice were inoculated first in the right hind footpad with 5,000 M. leprae and then challenged in the left hind footpad with 5,000 M. leprae of the same strain at intervals after primary infection, at the same time that uninfected mice were inoculated. Multiplication of the M. leprae of the secondary challenge inoculum occurred at the same rate and to the same level as multiplication in uninfected mice when challenges were made soon after primary infection. Multiplication was slowed but proceeded to the same level in previously infected as in uninfected mice when the challenges were administered between 76 and 106 days after primary infection (47 to 17 days before the M. leprae of the primary inoculum had multiplied to the level of 10-6 organisms per footpad). Finally, the M. leprae of a secondary challenge administered at the time that the organisms of the primary inoculum had multiplied to 10-6 per footpad or later not only multiplied more slowly in previously infected than in control animals, but multiplication in the previously infected animals reached a lower maximum. These results are similar to those observed when mice previously infected with M. bovis (BCG), M. marinum, Toxoplasma gondii, or Besnoitia jellisoni were challenged with M. leprae.

Full text

PDF
1094

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Evans M. J., Levy L. Ultrastructural changes in cells of the mouse footpad infected with Mycobacterium leprae. Infect Immun. 1972 Feb;5(2):238–247. doi: 10.1128/iai.5.2.238-247.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Evans M. J., Newton H. E., Levy L. Early response of mouse foot pads to Mycobacterium laprae. Infect Immun. 1973 Jan;7(1):76–85. doi: 10.1128/iai.7.1.76-85.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gaugas J. M. Enhancing effect of antilymphocytic globulin on human leprosy infection in thymectomized mice. Nature. 1968 Dec 21;220(5173):1246–1248. doi: 10.1038/2201246a0. [DOI] [PubMed] [Google Scholar]
  4. Krahenbuhl J. L., Levy L., Remington J. S. Resistance to Mycobacterium leprae in Mice Infected with Toxoplasma gondii and Besnoitia jellisoni. Infect Immun. 1974 Nov;10(5):1068–1071. doi: 10.1128/iai.10.5.1068-1071.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Levy L. Death of Mycobacterium leprae in mice, and the additional effect of dapsone administration. Proc Soc Exp Biol Med. 1970 Dec;135(3):745–749. doi: 10.3181/00379727-135-35134. [DOI] [PubMed] [Google Scholar]
  6. Navalkar R. G., Patel P. J., Dalvi R. R., Levy L. Immune response to Mycobacterium leprae: plaque-forming cells in mice. Infect Immun. 1974 Dec;10(6):1302–1306. doi: 10.1128/iai.10.6.1302-1306.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ng H., Jacobsen P. L., Levy L. Analogy of Mycobacterium marinum disease to Mycobacterium leprae infection in footpads of mice. Infect Immun. 1973 Dec;8(6):860–867. doi: 10.1128/iai.8.6.860-867.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Rees R. J. Enhanced susceptibility of thymectomized and irradiated mice to infection with Mycobacterium leprae. Nature. 1966 Aug 6;211(5049):657–658. doi: 10.1038/211657a0. [DOI] [PubMed] [Google Scholar]
  9. SHEPARD C. C. VACCINATION AGAINST EXPERIMENTAL INFECTION WITH MYCOBACTERIUM LEPRAE. Am J Epidemiol. 1965 Mar;81:150–163. doi: 10.1093/oxfordjournals.aje.a120504. [DOI] [PubMed] [Google Scholar]
  10. Shepard C. C. A comparison of the effectiveness of two freeze-dried BCG vaccines against Mycobacterium leprae in mice. Bull World Health Organ. 1968;38(1):135–140. [PMC free article] [PubMed] [Google Scholar]
  11. Shepard C. C., Chang Y. T. Effect of DDS on established infections with Mycobacterium leprae in mice. Int J Lepr Other Mycobact Dis. 1967 Jan-Mar;35(1):52–57. [PubMed] [Google Scholar]
  12. Shepard C. C., Congdon C. C. Increased growth of Mycobacterium leprae in thymectomized-irradiated mice after foot pad inoculation. Int J Lepr Other Mycobact Dis. 1968 Apr-Jun;36(2):224–227. [PubMed] [Google Scholar]
  13. Shepard C. C., Habas J. A. Relation of infection to tissue temperature in mice infected with Mycobacterium marinum and Mycobacterium leprae. J Bacteriol. 1967 Mar;93(3):790–796. doi: 10.1128/jb.93.3.790-796.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Shepard C. C., McRae D. H. A method for counting acid-fast bacteria. Int J Lepr Other Mycobact Dis. 1968 Jan-Mar;36(1):78–82. [PubMed] [Google Scholar]
  15. Shepard C. C. Vaccination against human leprosy bacillus infections of mice: protection by BCG given during the incubation period. J Immunol. 1966 Feb;96(2):279–283. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES